These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 29346467

  • 1. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
    Michels KA, Pfeiffer RM, Brinton LA, Trabert B.
    JAMA Oncol; 2018 Apr 01; 4(4):516-521. PubMed ID: 29346467
    [Abstract] [Full Text] [Related]

  • 2. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
    Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER.
    Cancer Epidemiol Biomarkers Prev; 2013 Nov 01; 22(11):1931-43. PubMed ID: 24014598
    [Abstract] [Full Text] [Related]

  • 3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB, Porterfield D.
    Contraception; 1992 Feb 01; 45(2):93-104. PubMed ID: 1559340
    [Abstract] [Full Text] [Related]

  • 4. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
    Gwinn ML.
    J Obstet Gynaecol (Lahore); 1985 Jan 01; 5 Suppl 2():S83-7. PubMed ID: 12268773
    [Abstract] [Full Text] [Related]

  • 5. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E, Malone KE, Weiss NS, Daling JR.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):505-14. PubMed ID: 8133534
    [Abstract] [Full Text] [Related]

  • 6. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
    Pfeiffer RM, Park Y, Kreimer AR, Lacey JV, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P.
    PLoS Med; 2013 Apr 06; 10(7):e1001492. PubMed ID: 23935463
    [Abstract] [Full Text] [Related]

  • 7. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC.
    Am J Obstet Gynecol; 2017 Jun 06; 216(6):580.e1-580.e9. PubMed ID: 28188769
    [Abstract] [Full Text] [Related]

  • 8. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
    Schlesselman JJ.
    Contraception; 1989 Jul 06; 40(1):1-38. PubMed ID: 2673658
    [Abstract] [Full Text] [Related]

  • 9. The pill and cancer: a review of the literature. A case of swings and roundabouts?
    Knowlden HA.
    J Adv Nurs; 1990 Sep 06; 15(9):1016-20. PubMed ID: 2229699
    [Abstract] [Full Text] [Related]

  • 10. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
    Karlsson T, Johansson T, Höglund J, Ek WE, Johansson Å.
    Cancer Res; 2021 Feb 15; 81(4):1153-1162. PubMed ID: 33334812
    [Abstract] [Full Text] [Related]

  • 11. Net effect of oral contraceptive use on the risk of cancer in women in the United States.
    Schlesselman JJ.
    Obstet Gynecol; 1995 May 15; 85(5 Pt 1):793-801. PubMed ID: 7724116
    [Abstract] [Full Text] [Related]

  • 12. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM.
    Am J Obstet Gynecol; 1992 Oct 15; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [Abstract] [Full Text] [Related]

  • 13. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative.
    Cespedes Feliciano EM, Hohensee C, Rosko AE, Anderson GL, Paskett ED, Zaslavsky O, Wallace RB, Caan BJ.
    JAMA Netw Open; 2020 Sep 01; 3(9):e2016747. PubMed ID: 32926116
    [Abstract] [Full Text] [Related]

  • 14. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
    Kok VC, Tsai HJ, Su CF, Lee CK.
    Int J Gynecol Cancer; 2015 Jul 01; 25(6):968-76. PubMed ID: 25893280
    [Abstract] [Full Text] [Related]

  • 15. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL, Peterson HB.
    Contracept Technol Update; 1985 Jan 01; 6(1):7-12. PubMed ID: 12279918
    [Abstract] [Full Text] [Related]

  • 16. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
    Urban M, Banks E, Egger S, Canfell K, O'Connell D, Beral V, Sitas F.
    PLoS Med; 2012 Jan 01; 9(3):e1001182. PubMed ID: 22412354
    [Abstract] [Full Text] [Related]

  • 17. Sugar-containing beverages and their association with risk of breast, endometrial, ovarian and colorectal cancers among Canadian women.
    Arthur RS, Kirsh VA, Mossavar-Rahmani Y, Xue X, Rohan TE.
    Cancer Epidemiol; 2021 Feb 01; 70():101855. PubMed ID: 33220638
    [Abstract] [Full Text] [Related]

  • 18. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D.
    BMJ; 1989 Dec 16; 299(6714):1487-91. PubMed ID: 2514858
    [Abstract] [Full Text] [Related]

  • 19. Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study.
    Michels KA, Brinton LA, Pfeiffer RM, Trabert B.
    Am J Epidemiol; 2018 Aug 01; 187(8):1630-1641. PubMed ID: 29394309
    [Abstract] [Full Text] [Related]

  • 20. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.
    Brinton LA, Gammon MD, Malone KE, Schoenberg JB, Daling JR, Coates RJ.
    Contraception; 1997 Apr 01; 55(4):197-203. PubMed ID: 9179450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.